International Linked Clinical Trials (iLCT)
28 results.
LONDON (Feb. 13, 2020) — The Cure Parkinson’s Trust (CPT) and Van Andel Institute (VAI) are delighted to announce a new three-year co-funding agreement that…
The Cure Parkinson's Trust (CPT) is delighted to announce the publication of the results of a Phase II clinical trial evaluating ambroxol as a…
Institute serves as a connector that fosters discovery of potential new treatments
Clinical trials can be a bastion of hope for people living…
This story originally appeared on The Cure Parkinson’s Trust website. To learn more, click here.
It was announced today that the Australian Parkinson's…
Did you miss Grand Challenges in Parkinson’s Disease and Rallying to the Challenge? Don’t worry. We have you covered.
Just over a week ago, the…
Part three: What we’re doing to move lab discoveries into the clinic
In the past few weeks, VAI Voice has discussed what it takes to translate a promising laboratory discovery into a life-changing, approved treatment. In our…
Part two: Before a new medication can be used in patients, it must go through a gauntlet of tests to ensure it is safe and effective
In the second installment in our multi-part series on how a new medication moves from the lab to the doctor’s office, we take a look…
Evidence continues to mount that a newer class of anti-diabetic drugs called incretin mimetics, or glucagon-like peptide-1 receptor agonists, could slow…